⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417091 | 1.00 | — | — | |
| SCHEMBL17591768 | 1.00 | — | — | |
| SCHEMBL18074175 | 0.85 | — | — | |
| SCHEMBL358401 | 0.80 | — | — | |
| SCHEMBL13654262 | 0.76 | — | — | |
| SCHEMBL6675935 | 0.76 | — | — | |
| SCHEMBL118430 | 0.76 | — | — | |
| SCHEMBL10266692 | 0.76 | — | — | |
| SCHEMBL12738142 | 0.76 | — | — | |
| SCHEMBL2632247 | 0.73 | MAPT (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250311759-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-09 | — | — | US | claimed |
| CN-119836236-A | Organic compound | 奇华顿股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20210198252-A1 | SMYD INHIBITORS | EPIZYME INC (US) | 2021-07-01 | — | — | US | claimed |
| US-20200048195-A1 | SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS | Epizyme, Inc. | 2020-02-13 | — | — | US | claimed |
| US-20190322660-A1 | SMYD INHIBITORS | Epizyme, Inc. | 2019-10-24 | — | — | US | claimed |
| US-20170355695-A1 | SMYD Inhibitors | Epizyme, Inc. (US) | 2017-12-14 | — | — | US | claimed |
| US-20170247326-A1 | Substituted Pyrrolidine Carboxamide Compounds | Epizyme, Inc. (US) | 2017-08-31 | — | — | US | claimed |
| EP-3193600-A1 | SMYD INHIBITORS | Epizyme, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| EP-3193609-A1 | SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS | Epizyme, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| WO-2016040508-A1 | SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS | Epizyme, Inc. (US) | 2016-03-17 | — | — | WO | claimed |
| WO-2016040505-A1 | SMYD INHIBITORS | Epizyme, Inc. (US) | 2016-03-17 | — | — | WO | claimed |
| US-20070056900-A1 | Use of copolymers containing n-vinyl lactam for producing functionalized membranes | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | claimed |
| US-20250311759-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-09 | — | — | US | disclosed |
| CN-119836236-A | Organic compound | 奇华顿股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| US-20230101819-A1 | SMYD Inhibitors | EPIZYME INC (US) | 2023-03-30 | — | — | US | disclosed |
| CN-115028619-A | SMYD inhibitors | EPIZYME股份有限公司 | 2022-09-09 | — | — | CN | disclosed |
| EP-1667789-A2 | USE OF COPOLYMERS CONTAINING N-VINYL LACTAM FOR PRODUCING FUNCTIONALIZED MEMBRANES | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005032701-A2 | USE OF COPOLYMERS CONTAINING N-VINYL LACTAM FOR PRODUCING FUNCTIONALIZED MEMBRANES | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-14 | — | — | WO | disclosed |
| US-5747616-A | 1-VINYLIMIDAZOLE AND DIALKYLAMINOALKYL VINYL ETHER COMONOMERS; GOOD COLD FILTER PLUGGING POINT | BASF AKTIENGESELLSCHAFT (DE) | 1998-05-05 | — | — | US | disclosed |
| US-5684108-A | VINYL ESTER AND AMINOALKYL (METH)ACRYLATE COMONOMERS | BASF AKTIENGESELLSCHAFT (DE) | 1997-11-04 | — | — | US | disclosed |